VITROS Immunodiagnostic Products hs Troponin I

UnknownOBSERVATIONAL
Enrollment

1,630

Participants

Timeline

Start Date

June 7, 2018

Primary Completion Date

May 30, 2020

Study Completion Date

June 30, 2021

Conditions
Acute Coronary Syndrome (ACS)Myocardial Infarction
Trial Locations (24)

11794

Stony Brook University Hospital, Stony Brook

19107

Thomas Jefferson University Hospital, Philadelphia

21201

University of Maryland, Baltimore

22304

INOVA Alexandria Hospital, Alexandria

25304

Charleston Area Medical Center, Charleston

27157

Wake Forest University Health Sciences, Winston-Salem

29298

Virginia Commonwealth University Medical Center, Richmond

29425

Medical University of South Carolina, Charleston

36106

Drug Research and Analysis Corp, Montgomery

45267

University of Cincinnati, Cincinnati

48073

Beaumont, Royal Oak

48201

Wayne State University/Detroit Receiving Hospital, Detroit

48202

Henry Ford Health System, Detroit

53226

Medical College of Wisconsin and Froedtert Hospital, Milwaukee

55404

Hennepin County Medical Center/Minneapolis Medical Research Foundation, Minneapolis

66160

University of Kansas Medical Center, Kansas City

75390

UT Southwestern Medical Center, Dallas

77030

Ben Taub General Hospital / Baylor College of Medicine/Harris Health System, Houston

79905

Texas Tech University Health Sciences Center El Paso, El Paso

85224

Chandler Regional Medical Center, Chandler

97239

Oregon Health Science University Hospital, Portland

06519

Yale New Haven Hospital, New Haven

02114

Mass General Hospital, Boston

08103

Cooper University Hospital, Camden

All Listed Sponsors
lead

Ortho-Clinical Diagnostics, Inc.

INDUSTRY

NCT03581578 - VITROS Immunodiagnostic Products hs Troponin I | Biotech Hunter | Biotech Hunter